Suki AI Alternative for Orthopedic Surgeons: CPT 20610 ROM Documentation Playbook (2026)

Documenting CPT 20610 with defensible range of motion measurements requires goniometric degrees for the affected joint, comparison to the contralateral side, failed conservative therapy, and a Modifier 25 E/M narrative that stands apart from the injection note, captured as structured fields rather than free-text ambient summaries.

Goniometric ROM degrees separate reimbursable E/M services from bundled CPT 20610 work

CLINICAL UPDATE 2026: Revised for 2026 CMS CPT G2211 attestation rules, California SB 1120 compliance, and NCCI Modifier 25 bundling criteria.

CPT 20610 carries a zero-day global period, which means CMS and commercial payers treat the pre-procedure assessment as part of the injection itself. Under National Correct Coding Initiative (NCCI) policy, the decision to perform a minor procedure is included in the procedure payment. A same-day E/M service is payable only when it is significant and separately identifiable, and the clearest evidence of that separation is objective, quantified examination data.

Range of motion degrees are the most auditable form of that evidence. A note stating "decreased ROM, painful" gives an auditor nothing to evaluate. A note stating "right knee flexion 0 to 95 degrees active, 0 to 105 degrees passive, versus left knee 0 to 135 degrees, with 5-degree extension lag" establishes functional deficit, laterality, severity, and a baseline for future medical necessity decisions on repeat injections or hyaluronic acid series.

Medical directors should treat ROM as a required data element, not optional narrative. Every injection visit should produce measurements that can be trended across encounters, because payers reviewing a third corticosteroid injection in twelve months will ask whether the prior injections produced measurable functional improvement. Without degrees recorded at each visit, the clinic cannot answer that question.

Minimum ROM data set per joint

• Knee (20610, 20611): flexion and extension in degrees, extension lag, effusion grade, comparison to contralateral knee.

• Shoulder and subacromial bursa: forward flexion, abduction, external rotation at 0 and 90 degrees abduction, internal rotation by vertebral level.

• Hip (typically 20611 with imaging): flexion, internal and external rotation at 90 degrees flexion, FADIR and FABER findings.

• Active versus passive distinction: record both when they differ, since the gap supports differential diagnosis work.

General-purpose ambient scribes often miss structured fields orthopedic injection audits require

Orthopedic groups evaluating a Suki AI alternative are usually not dissatisfied with transcription accuracy. Suki and similar ambient assistants capture conversation and produce readable narrative notes across many specialties. The operational gap appears when the note must function as a billing artifact: discrete ROM values, laterality modifiers, drug units, NDC-level detail, and a clean boundary between the E/M section and the procedure section.

Ambient summarization tends to compress numbers into prose. A surgeon who says "she's got about ninety degrees of flexion, maybe a hundred passively" during the exam may see that rendered as "limited flexion noted" in a generalized summary. That compression is clinically harmless but financially costly, because the summarized phrase cannot be defended in a Modifier 25 audit and cannot be trended over time.

Specialty-specific documentation engines handle this differently. The Scribing.io Clinical Interface maps spoken measurements to discrete joint-specific fields, flags missing contralateral comparisons, and separates the E/M assessment from the procedure note by design. Orthopedic templates in the Specialty Clinical Documentation Library are built around the elements payers actually request in post-payment review.

Evaluation criteria for any ambient scribe replacement

• Discrete numeric ROM capture: degrees preserved as values, not paraphrased into adjectives.

• Procedure note separation: injection details isolated from the E/M history and exam.

• Drug and unit fidelity: HCPCS J-code units calculated from spoken dose.

• Laterality enforcement: RT, LT, or modifier 50 prompted before note finalization.

• Repeat-injection trending: prior ROM and response pulled forward automatically.

Medical directors should request a side-by-side pilot rather than a feature demo. Run ten injection encounters through each tool, then have a certified coder audit the output against the criteria above. The comparison usually surfaces differences in field-level capture that a demo script will not reveal.

CPT 20610 procedure notes must document seven elements to survive payer review

The procedure note for arthrocentesis or major joint injection is a separate document component from the E/M service. It should be complete enough that a reviewer could reconstruct the procedure without reading the assessment. Incomplete procedure notes are among the most common reasons for 20610 recoupment, independent of any Modifier 25 issue.

1. Indication and informed consent: diagnosis, risks discussed (infection, flare, skin depigmentation, glucose elevation), and consent obtained.

2. Site and laterality: specific joint or bursa, side, and approach (superolateral, anteromedial, posterior subacromial).

3. Preparation: skin antisepsis agent, sterile technique, time-out confirmation.

4. Needle and anesthetic: gauge, length, and local anesthetic agent with volume.

5. Aspiration findings: volume aspirated in milliliters, fluid character, and whether fluid was sent for analysis.

6. Medication injected: drug name, dose in milligrams, volume, and lot number where required.

7. Tolerance and post-procedure plan: complications or absence of them, post-injection instructions, follow-up interval.

Drug dose must reconcile with HCPCS unit billing. Methylprednisolone acetate bills under J1030 (40 mg) or J1040 (80 mg), triamcinolone acetonide under J3301 per 10 mg, and extended-release triamcinolone under J3304. A note documenting "40 mg Kenalog" must produce four units of J3301. When the spoken dose and the billed units diverge, the claim is vulnerable regardless of clinical quality.

Ultrasound guidance changes the code. CPT 20611 requires ultrasound guidance with permanent recording and reporting. NCCI edits bundle 76942 into 20611, so separate ultrasound guidance billing is not appropriate. The note must state that images were archived and must describe needle placement visualization. Without a permanent image record, 20611 should be downcoded to 20610.

Modifier 25 requires an E/M story that exists without the injection

The core Modifier 25 test is whether the E/M note would justify a billable visit if the injection had never occurred. If the only work performed was confirming a known diagnosis and deciding to inject, the E/M is bundled. If the surgeon evaluated a new complaint, worked up a differential, reviewed imaging, adjusted medications, or managed a separate problem, the E/M is separately identifiable. See Managing Modifier 25 Clinical Revenue Integrity for a full framework.

Established patients returning for scheduled injections rarely support Modifier 25. A patient on a planned hyaluronic acid series who reports no change and receives injection two of three has no separately identifiable E/M. Billing a 99213-25 in that scenario is a frequent target in payer data analytics, because the pattern of E/M plus 20610 on every visit is statistically visible.

New problems and worsening conditions are where Modifier 25 is legitimate. Examples include a patient presenting for a knee injection who also reports new shoulder pain requiring examination, a patient whose knee ROM has declined by 20 degrees since the prior visit prompting imaging review and surgical discussion, or a patient with new mechanical symptoms requiring a meniscal exam and MRI order.

Narrative elements that support Modifier 25

• Interval change with numbers: "Flexion decreased from 115 to 95 degrees since last visit."

• Failed conservative therapy: named NSAID, duration, physical therapy sessions completed, prior injection response.

• Imaging interpretation: independent review of radiographs with Kellgren-Lawrence grade documented.

• Management decisions beyond injection: bracing, surgical referral, medication change, activity modification.

• Separate diagnosis where applicable: a second problem addressed with its own assessment.

Diagnosis codes do not need to differ between the E/M and the procedure for Modifier 25 to apply, but the documentation must show work beyond the pre-procedure evaluation. Medical directors should coach surgeons that a different diagnosis strengthens the claim but is not mandatory, and that identical diagnoses demand an especially clear narrative of separate cognitive work.

Audit rule: remove the injection mentally; the E/M must still stand alone.

A four-column audit matrix maps every 20610 parameter to defensible documentation

The table below translates payer expectations into operational requirements. Each row identifies the clinical parameter, what the note must contain, where audits typically find failure, and how structured capture in Scribing.io addresses the gap through its document object model (DOM) field mapping.

Clinics can deploy these structures immediately through the 1,000+ Specialty Clinical Macros, which include knee, shoulder, hip, and bursa injection templates with ROM fields preconfigured for each joint.

G2211 is not payable on a Modifier 25 E/M paired with 20610

The G2211 visit complexity add-on recognizes the longitudinal relationship between a clinician and a patient with a serious or complex condition. Many orthopedic practices managing chronic osteoarthritis began reporting G2211 after its 2024 activation, and the 2026 environment requires careful attention to when the code is permissible.

CMS policy finalized for CY 2025 allows G2211 with an E/M carrying Modifier 25 only when the same-day service is an annual wellness visit, vaccine administration, or a Medicare Part B preventive service furnished in the office. A Modifier 25 E/M billed alongside 20610 does not meet that exception, so G2211 should not be reported on those claims. Directors should verify current CMS Physician Fee Schedule language annually, since this policy has changed twice since activation.

G2211 remains appropriate on standalone E/M visits where the orthopedic surgeon serves as the continuing focal point for a serious condition. Examples include a non-injection follow-up for advanced knee osteoarthritis where the surgeon manages the longitudinal plan. The attestation should describe the ongoing relationship explicitly, not merely state the code was applied.

G2211 attestation language for orthopedic visits

• Relationship statement: "I am the continuing focal point for this patient's progressive osteoarthritis care."

• Longitudinal plan: reference to the multi-visit management strategy, including surgical timing decisions.

• Exclusion check: confirm no same-day minor procedure with Modifier 25 on the claim.

Automated claim logic should block G2211 whenever 20610, 20611, or other minor procedures appear on the same date with a Modifier 25 E/M, unless a qualifying preventive service is also present. Building this rule into the documentation layer prevents the error before it reaches the billing team.

California SB 1120 makes physician-specific documentation the defense against algorithmic denials

California Senate Bill 1120, effective January 1, 2025, requires that health plans and disability insurers using artificial intelligence in utilization review ensure that medical necessity determinations are made by a licensed physician or qualified health care provider, based on the individual patient's clinical history and circumstances. An algorithm cannot deny, delay, or modify care on its own.

The practical effect for orthopedic groups is that individualized documentation now carries more weight in appeals. When a payer flags a hyaluronic acid series or a repeat corticosteroid injection, the reviewing physician must evaluate the patient's specific record. Notes containing quantified ROM trends, named failed therapies, and imaging grades give that reviewer a concrete basis to approve. Generic notes give the reviewer nothing to override an algorithmic flag.

Clinics using AI documentation tools should also observe California AB 3030, which requires disclosure when generative AI produces patient clinical communications without provider review. Ambient scribes that draft notes for physician signature fall outside that disclosure trigger when a licensed clinician reviews the output, but patient-facing portal messages generated by AI require attention. Medical directors should confirm their vendor's workflow keeps a clinician in the review loop.

Appeal principle: individualized ROM data gives physician reviewers grounds to approve.

Diagnosis code specificity determines whether 20610 or 20550 is correct

Procedure code selection follows the anatomic target, and diagnosis codes must align. A right knee osteoarthritis injection pairs M17.11 (ICD-10-CM), unilateral primary osteoarthritis of the right knee, with 20610 or 20611. Unspecified codes such as M17.9 frequently fail local coverage criteria for hyaluronic acid and invite denials even for corticosteroid injections.

Tendon sheath injections are not major joint injections. A patient with de Quervain tenosynovitis, coded as M65.4 (ICD-10-CM) radial styloid tenosynovitis, receives an injection into the first dorsal compartment tendon sheath, which reports as CPT 20550, not 20610. Hand and upper extremity clinics that default to 20610 for wrist-area injections create a coding mismatch auditors identify quickly.

Joint size and code mapping reference

• Major joint or bursa: knee, shoulder, hip, subacromial bursa, report 20610 or 20611.

• Intermediate joint or bursa: wrist, elbow, ankle, olecranon bursa, report 20605 or 20606.

• Small joint: fingers, toes, report 20600 or 20604.

• Tendon sheath or ligament: de Quervain, trigger finger, report 20550.

Documentation engines should link exam laterality and anatomic site to code suggestions. When a surgeon documents a right knee exam and a right knee injection, the system should propose M17.11 and 20610-RT together and flag any inconsistency, such as a left-sided diagnosis paired with a right-sided procedure.

Medical directors should deploy a 30-day rollout to replace generic ambient scribing

Transitioning from a general ambient assistant to a specialty documentation platform works best as a structured pilot. Abrupt switches disrupt clinic flow and produce resistance from surgeons who have built habits around their current tool. A phased approach lets the clinic measure documentation quality before committing.

Week 1: baseline audit

Pull twenty recent 20610 claims with a same-day E/M and have a certified coder score each against the audit matrix above. Record the percentage of notes with numeric ROM, contralateral comparison, named failed therapy, and correct J-code units. This baseline becomes the benchmark for the pilot.

Week 2: template configuration

Configure joint-specific injection templates for the clinic's most common procedures. Most orthopedic practices find that knee, shoulder, and subacromial bursa account for the majority of 20610 volume. Load the clinic's preferred corticosteroid formulary so dose-to-unit conversion matches the supply room.

Week 3: surgeon pilot

Select two surgeons with high injection volume and run all injection encounters through the new platform. Train them to speak measurements explicitly ("right knee flexion ninety-five active") rather than approximately. Collect feedback daily on note accuracy and time to sign.

Week 4: comparative audit and decision

Repeat the coder audit on twenty pilot encounters and compare against baseline. Measure field completion rates, Modifier 25 defensibility scores, and G2211 error rates. Present findings to the surgeon group with specific note examples, since surgeons respond to concrete before-and-after comparisons more than to summary statistics.

Ongoing compliance monitoring should continue after rollout. Schedule quarterly audits of ten injection encounters per surgeon, track the ratio of Modifier 25 E/M services to total injection encounters, and investigate any surgeon whose ratio substantially exceeds the group norm. Pattern outliers attract payer attention before individual claims do.

Frequently asked questions about CPT 20610 ROM documentation and Suki AI alternatives

What ROM documentation does CPT 20610 with Modifier 25 require?

Payers expect goniometric degrees for the affected joint, ideally active and passive values, with a contralateral comparison and interval change from prior visits. These measurements demonstrate a separately identifiable evaluation. Adjective-only descriptions such as "limited motion" rarely survive Modifier 25 audits because they show no quantifiable clinical work beyond the injection decision.

Can G2211 be billed with a 20610 injection visit?

Not when the E/M carries Modifier 25 for a same-day 20610 procedure. CMS permits G2211 with Modifier 25 only when the same-day service is an annual wellness visit, vaccine administration, or Medicare Part B preventive service. Standalone orthopedic E/M visits without procedures may still qualify when longitudinal care criteria are documented clearly.

When should 20611 be billed instead of 20610?

Bill 20611 only when ultrasound guidance is used with permanent image recording and a written report describing needle placement. NCCI bundles 76942 into 20611, so ultrasound guidance cannot be billed separately. If images were not archived, the procedure should be reported as 20610, even when ultrasound was used during the injection.

Why do orthopedic surgeons seek a Suki AI alternative?

Orthopedic practices often need discrete numeric fields for ROM, laterality enforcement, J-code unit conversion, and strict separation between E/M and procedure sections. General ambient assistants produce strong narrative notes but may summarize measurements into prose. Specialty platforms such as Scribing.io preserve billing-critical data as structured, auditable fields for injection encounters.

Is a de Quervain injection billed as CPT 20610?

No, de Quervain tenosynovitis injections target the first dorsal compartment tendon sheath and are reported with CPT 20550, paired with ICD-10-CM M65.4. CPT 20610 applies only to major joints or bursae such as the knee, shoulder, hip, or subacromial bursa. Misassigning 20610 to tendon sheath injections creates clear audit exposure.